Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
NeoGenomics Inc has a consensus price target of $19.15 based on the ratings of 14 analysts. The high is $26 issued by Craig-Hallum on May 1, 2024. The low is $15 issued by SVB Leerink on November 9, 2022. The 3 most-recent analyst ratings were released by Needham, Benchmark, and Stephens & Co. on September 25, 2024, September 24, 2024, and July 30, 2024, respectively. With an average price target of $18.67 between Needham, Benchmark, and Stephens & Co., there's an implied 21.05% upside for NeoGenomics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for NeoGenomics (NASDAQ:NEO) was reported by Needham on September 25, 2024. The analyst firm set a price target for $19.00 expecting NEO to rise to within 12 months (a possible 23.22% upside). 22 analyst firms have reported ratings in the last year.
The latest analyst rating for NeoGenomics (NASDAQ:NEO) was provided by Needham, and NeoGenomics reiterated their buy rating.
The last upgrade for NeoGenomics Inc happened on August 21, 2023 when Stephens & Co. raised their price target to $18. Stephens & Co. previously had an equal-weight for NeoGenomics Inc.
The last downgrade for NeoGenomics Inc happened on May 16, 2023 when Raymond James changed their price target from N/A to N/A for NeoGenomics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeoGenomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeoGenomics was filed on September 25, 2024 so you should expect the next rating to be made available sometime around September 25, 2025.
While ratings are subjective and will change, the latest NeoGenomics (NEO) rating was a reiterated with a price target of $19.00 to $19.00. The current price NeoGenomics (NEO) is trading at is $15.42, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.